Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
- Status
- COMPLETED
- Phase
- PHASE4
A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.
- Status
- COMPLETED
- Phase
- PHASE4
An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder
- Status
- COMPLETED
- Phase
- PHASE2
CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
- Status
- COMPLETED
- Phase
- PHASE3
Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene
- Status
- COMPLETED
- Phase
- PHASE3
Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Exposure-Response in Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
- Status
- TERMINATED
- Phase
- PHASE3
The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes
- Status
- TERMINATED
- Phase
- PHASE4
Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
I PREVENT - Irbesartan In Hypertensive Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE4
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
- Status
- COMPLETED
- Phase
- PHASE4
Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment
- Status
- COMPLETED
- Phase
- PHASE2
An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Severe Hypoglycemia in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4